Biography
Jenny counsels and represents innovative life sciences and medical technology companies in intellectual property disputes from initial case development through trial and appeal.
She regularly practices in US District Courts around the country and has appeared before the ITC, the PTAB, the Federal Circuit Court of Appeals and various international arbitration bodies.
Whether preparing a witness, drafting a brief, or advising a client on strategy, Jenny aims to distill complex concepts into actionable steps and relatable narratives. She draws from her broad experience representing companies across a spectrum of industries and stages, teaching legal writing to law students and clerking at the US Court of Appeals for the Federal Circuit (Hon. Jimmie V. Reyna) and the US District Court for the Eastern District of Pennsylvania (Hon. Cynthia Rufe).
Jenny maintains an active pro bono practice and serves in leadership roles in the Giles S. Rich Inn of Court and the Federal Circuit Bar Association.
Experience
Representative Matters
A group of pharmaceutical companies in Hatch-Waxman litigation against companies seeking approval for generic versions of the commercial product, AVYCAZ®.*
Esperion in Hatch-Waxman litigation against companies seeking approval for generic versions of the commercial products, NEXLITOL® and Nexlizet®.*
Insulet Corp. in trade secret misappropriation suit involving the OMNIPOD® insulin patch-pump device, winning preliminary injunction, 9-digit jury verdict and subsequent permanent injunction.*
A multinational pharmaceutical corporation in appeal of an infringement judgment in litigation brought by Plexxicon.*
A multinational pharmaceutical corporation in ITC investigation and related district court litigation asserting the pharmaceutical corporation’s pre-filled syringe patent against Regeneron’s EYLEA® (aflibercept) product.*
Celltrion in parallel BPCIA patent infringement and inter partes review proceedings involving Celltrion’s proposed biosimilar to the oncology drug, Herceptin® (trastuzumab).*
E. & J. Gallo Winery in patent litigation related to variable rate irrigation technology.*
Global pharmaceutical manufacturers in various non-public representations, including pre-suit investigations and international arbitrations.*
*Experience prior to joining White & Case.
Pro bono
Representation of veterans challenging denial of disability benefits in submitting petitions for rehearing en banc at the Federal Circuit. Champagne v. Collins (Fed. Cir.); Steele v. Collins (Fed. Cir.).*
Representation of the Federal Circuit Bar Association as amicus curiae in veterans’ benefit cases, co-authoring cert-stage and merits-stage amicus briefs on regulatory and statutory interpretation questions, Veteran Warriors, Inc. v. Secretary of Veterans Affairs (SCOTUS); Bufkin v. McDonough (SCOTUS).*
Representation of coalition of minority-veterans’ organizations as amici curiae challenging the constitutionality of sex-based Selective Service registration requirement, National Coalition for Men v. Selective Service System (SCOTUS).*
Representation of CATO Institute and Florida Association of Criminal Defense Lawyers as amici curiae challenging the Eleventh Circuit’s interpretation of the harmless-error standard in criminal cases, Pon v. United States (SCOTUS).*
Successfully challenging, on First Amendment grounds, an anti-panhandling ordinance enacted by the City of Lowell, MA on behalf of homeless residents, McLaughlin v. City of Lowell (D. Mass.).*
Winning a preliminary injunction, on Eighth Amendment and ADA grounds, against a prison’s denial of methadone treatment to an inmate recovering from opioid use disorder, Pesce v. Coppinger (D. Mass.).*
Preparing a trial defense for indigent former healthcare insurance executive facing multiple federal healthcare fraud and identity theft charges, US v. Brettschneider (D. Mass.).*
Teaching scholarly writing as an adjunct professor at George Washington University Law School.*
*Experience prior to joining White & Case.
Harlan Fiske Stone Scholar
cum laude
Moderator, "Trade Secrets, Drugs, and Cherry Blossoms," Giles Rich Inn of Court Panel, March 13, 2025
Moderator, "Agency Deference and the Pro-Veteran Canon in Veteran’s Appeals: Where are we and where are we heading?," Federal Circuit Bar Association Webinar, May 9, 2024
Panelist, "IP Law Year in Review," Utah Bar Association IP Summit, February 16, 2024
Moderator, "Administrative Practice in Advance of Federal Circuit Review," Federal Circuit Bar Association Webinar, February 1, 2024
Moderator, "Trends in Administrative Law," Giles Rich Inn of Court Panel, November 14, 2023
Panelist, Foundation for Advancement of Diversity in IP Law Clerkship Panel, June 20, 2023
Presenter, "Retaining, Preparing, and Working with Expert Witnesses," TRTCLE: Bridge the Gap Compliance Day, January 29, 2023
"US Legislative Update: Takeaways for European Pharma," European Pharmaceutical Review, November 9, 2022
"Guide to Biosimilars Litigation and Regulation in the US, 2019-2020 ed," Thomson Reuters, November 2019
"Fed. Circ. Is Adhering to KSR Obviousness Guideposts," Law360, September 2015
"Distribution pattern of Plasmodium falciparum chloroquine transporter (pfcrt) gene haplotypes in Sri Lanka 1996-2006," American Journal of Tropical Medicine and Hygiene, November 2011